Please login to the form below

Not currently logged in
Email:
Password:

Paul Hudson

This page shows the latest Paul Hudson news and features for those working in and with pharma, biotech and healthcare.

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

The Sarclisa approval, and the new licence agreement with Eureka and MSK, aligns with Sanofi’s narrower focus – in 2019, the French pharma chief executive officer Paul Hudson revealed a new

Latest news

More from news
Approximately 3 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    3. Paul Hudson – taking the helm at Sanofi. Another new chief executive with a lot on his plate in 2020 is Paul Hudson, who took over from Olivier Brandicourt at French ... Hudson takes over Sanofi at a transitional time for the French group, which

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    In explaining how his company designs its R&D portfolio, Johnson &Johnson chief scientific officer Paul Stoffels said “quality of life is the first metric” on a 2019 conference call with ... The quality-of-life data is probably one of the single

  • NHS regional footprints NHS regional footprints

    By Steve How, Paul Midgley and Oli Hudson, all part of Wilmington Healthcare’s Consulting Team, see www.wilmingtonhealthcare.com.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Covid-19 drives change in long-term conditions management

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home. ... delivery. The time for digitally-supported pharma products is now. Ends. Paul Midgley is Director of NHS Insight and

  • Covid-19: how is it impacting on the NHS Long-term Plan?

    Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy. ... Ends. Oli Hudson is Content Director and Paul Midgley is Director of NHS Insight, both at Wilmington

  • How will the Tories’ historic win shape the NHS?

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.

  • 2019: A pivotal year for the NHS

    Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the key changes in the NHS in 2019. ... Ends. Paul Midgley is Director of NHS Insight and Oli Hudson is Content Director, both at Wilmington Healthcare.

  • Early diagnosis underpins NHS cancer strategy

    Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan. ... Ends. Paul Midgley is Director of NHS Insight; Sarah Shield is a Consultant and Oli Hudson is Content Director

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....